Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis
Inhibition of ADAM17 ameliorates high glucose-induced angiogenic and inflammatory responses in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression.
Authors
- Fang Wei (ORCID: https://orcid.org/0000-0001-8964-1645)
- Hao Feng (ORCID: https://orcid.org/0000-0003-4066-8104)
- Weizhen Xie (ORCID: https://orcid.org/0000-0003-4655-6496)
- Tingting Ding (ORCID: https://orcid.org/0000-0002-4537-9451)
- Leyi Gu
- Na Jiang (ORCID: https://orcid.org/0000-0002-5129-1448)
- Jiangzi Yuan
Institutions
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Nephrology
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1007/s10157-024-02546-y
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China